Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma.
Rolf W Sparidans
,
Hilde Rosing
,
Johannes J M Rood
,
Jan H M Schellens
,
Jos H Beijnen
More about this publication
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Volume
1033-1034
Pages
390-398
Publication date
15-10-2016
Full text links
Publisher website (DOI)
10.1016/j.jchromb.2016.09.012
Europe PubMed Central
27639128
Pubmed
27639128